337 related articles for article (PubMed ID: 29983334)
1. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS
Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302
[TBL] [Abstract][Full Text] [Related]
3. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G
Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520
[TBL] [Abstract][Full Text] [Related]
4. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
[TBL] [Abstract][Full Text] [Related]
5. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
[TBL] [Abstract][Full Text] [Related]
6. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.
Detzner J; Krojnewski E; Pohlentz G; Steil D; Humpf HU; Mellmann A; Karch H; Müthing J
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673393
[TBL] [Abstract][Full Text] [Related]
7. Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils.
Brigotti M; Carnicelli D; Arfilli V; Tamassia N; Borsetti F; Fabbri E; Tazzari PL; Ricci F; Pagliaro P; Spisni E; Cassatella MA
J Immunol; 2013 Nov; 191(9):4748-58. PubMed ID: 24068665
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
[TBL] [Abstract][Full Text] [Related]
9. Microparticle generation and leucocyte death in Shiga toxin-mediated HUS.
Ge S; Hertel B; Emden SH; Beneke J; Menne J; Haller H; von Vietinghoff S
Nephrol Dial Transplant; 2012 Jul; 27(7):2768-75. PubMed ID: 22234918
[TBL] [Abstract][Full Text] [Related]
10. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2.
Harrison LM; Gaines DW; Babu US; Balan KV; Reimschuessel R; Do AB; Pereira MR; Bigley EC; Ferguson M; Mehta A; Williams KM
Microb Pathog; 2018 Oct; 123():250-258. PubMed ID: 30016681
[TBL] [Abstract][Full Text] [Related]
11. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
Ibarra C; Amaral MM; Palermo MS
IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500
[TBL] [Abstract][Full Text] [Related]
12. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
13. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
[TBL] [Abstract][Full Text] [Related]
14. Shiga toxin-glycosphingolipid interaction: Status quo of research with focus on primary human brain and kidney endothelial cells.
Legros N; Pohlentz G; Steil D; Müthing J
Int J Med Microbiol; 2018 Dec; 308(8):1073-1084. PubMed ID: 30224239
[TBL] [Abstract][Full Text] [Related]
15. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene C4 increases the susceptibility of adult mice to Shiga toxin-producing Escherichia coli infection.
Cabrera G; Fernández-Brando RJ; Mejías MP; Ramos MV; Abrey-Recalde MJ; Vanzulli S; Vermeulen M; Palermo MS
Int J Med Microbiol; 2015 Dec; 305(8):910-7. PubMed ID: 26456732
[TBL] [Abstract][Full Text] [Related]
17. Rab7b participation on the TLR4 (Toll-like receptor) endocytic pathway in Shiga toxin-associated Hemolytic Uremic Syndrome (HUS).
Lafalla Manzano AF; Gil Lorenzo AF; Bocanegra V; Costantino VV; Cacciamani V; Benardon ME; Vallés PG
Cytokine; 2019 Sep; 121():154732. PubMed ID: 31153054
[TBL] [Abstract][Full Text] [Related]
18. Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.
Zoja C; Buelli S; Morigi M
Pediatr Nephrol; 2019 Mar; 34(3):379-388. PubMed ID: 29214442
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles and Renal Endothelial Cells: A Fatal Attraction in Hemolytic Uremic Syndrome.
Varrone E; Carnicelli D; Brigotti M
Am J Pathol; 2021 May; 191(5):795-804. PubMed ID: 33652019
[TBL] [Abstract][Full Text] [Related]
20. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release.
van Setten PA; Monnens LA; Verstraten RG; van den Heuvel LP; van Hinsbergh VW
Blood; 1996 Jul; 88(1):174-83. PubMed ID: 8704172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]